1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Blue Belt Technologies

Anonymous board for Blue Belt Technologies


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    1
    Views:
    7,107
  2. Anonymous
    Replies:
    0
    Views:
    4,322
  3. Anonymous
    Replies:
    4
    Views:
    6,623
  4. Anonymous
    Replies:
    4
    Views:
    4,652
  5. Anonymous
    Replies:
    0
    Views:
    3,814
  6. dspinerep
    Replies:
    1
    Views:
    3,809
  7. Anonymous
    Replies:
    0
    Views:
    2,821
  8. Anonymous
    Replies:
    0
    Views:
    2,462
  9. Anonymous
    Replies:
    0
    Views:
    2,685
  10. Anonymous
    Replies:
    3
    Views:
    3,176
  11. Anonymous
    Replies:
    6
    Views:
    3,652
  12. Anonymous
    Replies:
    3
    Views:
    3,442
  13. Anonymous
    Replies:
    0
    Views:
    2,511
  14. Anonymous
    Replies:
    1
    Views:
    2,431
  15. Anonymous
    Replies:
    2
    Views:
    3,115
  16. Anonymous
    Replies:
    2
    Views:
    2,889
  17. Anonymous
    Replies:
    0
    Views:
    2,582
  18. Anonymous
    Replies:
    5
    Views:
    4,133
  19. Anonymous
    Replies:
    1
    Views:
    3,880
  20. Anonymous
    Replies:
    1
    Views:
    2,819

Thread Display Options

Loading...